Summary
This report presents findings from a 30-country Ipsos Global Advisor survey conducted in October 2025, focusing on health perceptions and awareness of GLP-1 drugs. It documents that only 36% of respondents globally are aware of GLP-1 medications, with awareness significantly higher in the United States at 74%. The report highlights that social media is the primary source of information about these drugs, with 45% of respondents citing it as their source of awareness. Additionally, the report identifies mental health as the leading health concern, with 45% of participants across the surveyed countries recognizing it as a significant issue, surpassing concerns about cancer and obesity. The perception of mental health issues has notably increased since 2018, reflecting a growing awareness of its importance. The report also discusses healthcare satisfaction, revealing that 43% of respondents rate their healthcare quality as good, while concerns about future healthcare quality are prevalent, particularly in countries like France and Germany.
